APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gene Therapies for Tumor Treatment

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Gene Therapies for Tumor Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025186 pages

Choose your research edition.

Industry ResearchGene Therapies for Tumor Treatment Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Gene Therapies for Tumor Treatment Industry Growth and Trends Forecast to 203288 pages · $3,450 USDMarket StructureGlobal Gene Therapies for Tumor Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gene Therapies for Tumor Treatment Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Gene Therapies for Tumor Treatment Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gene Therapies for Tumor Treatment market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Gene Therapies for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Gene Therapies for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Gene Therapies for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Gene Therapies for Tumor Treatment is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Gene Therapies for Tumor Treatment include Shanghai Sunway, Novartis, Amgen, Sibiono and Gilead Sciences, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Gene Therapies for Tumor Treatment market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Gene Therapies for Tumor Treatment and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Gene Therapies for Tumor Treatment revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Gene Therapies for Tumor Treatment market size, projected growth trends, production technologies, key applications, and end-use industries.

Gene Therapies for Tumor Treatment Segment by Company

Shanghai Sunway

Novartis

Amgen

Sibiono

Gilead Sciences

Gene Therapies for Tumor Treatment Segment by Type

Oncolytic Virotherapy

Gene Transfer

Gene Induced Immunotherapy

Gene Therapies for Tumor Treatment Segment by Application

Hospital

Clinic

Other

Gene Therapies for Tumor Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gene Therapies for Tumor Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gene Therapies for Tumor Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gene Therapies for Tumor Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Gene Therapies for Tumor Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Gene Therapies for Tumor Treatment industry.

Chapter 3: Detailed analysis of Gene Therapies for Tumor Treatment companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gene Therapies for Tumor Treatmentrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Oncolytic Virotherapy Table 3. Key Players of Gene Transfer Table 4. Key Players of Gene Induced Immunotherapy Table 4. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospital Table 6. Key Players of Clinic Table 7. Key Players of Other Table 8. Global Gene Therapies for Tumor Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global Gene Therapies for Tumor Treatment Market Size by Region (2021-2026) & (US$ Million) Table 10. Global Gene Therapies for Tumor Treatment Market Share by Region (2021-2026) Table 11. Global Gene Therapies for Tumor Treatment Market Size by Region (2027-2032) & (US$ Million) Table 12. Global Gene Therapies for Tumor Treatment Market Share by Region (2027-2032) Table 13. Gene Therapies for Tumor Treatment Industry Trends Table 14. Gene Therapies for Tumor Treatment Industry Drivers Table 15. Gene Therapies for Tumor Treatment Industry Opportunities and Challenges Table 16. Gene Therapies for Tumor Treatment Industry Restraints Table 17. Global Gene Therapies for Tumor Treatment Revenue by Company (US$ Million) & (2021-2026) Table 18. Global Gene Therapies for Tumor Treatment Revenue Market Share by Company (2021-2026) Table 19. Global Gene Therapies for Tumor Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global Gene Therapies for Tumor Treatment Key Company Head Office and Area Served Table 21. Global Gene Therapies for Tumor Treatment Company, Product Type & Application Table 22. Global Gene Therapies for Tumor Treatment Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global Gene Therapies for Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global Gene Therapies for Tumor Treatment Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 27. Global Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 28. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2021-2026) Table 29. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2027-2032) Table 30. Global Gene Therapies for Tumor Treatment Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 32. Global Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 33. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2021-2026) Table 34. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2027-2032) Table 35. Shanghai Sunway Company Information Table 36. Shanghai Sunway Business Overview Table 37. Shanghai Sunway Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolio Table 39. Shanghai Sunway Recent Development Table 40. Novartis Company Information Table 41. Novartis Business Overview Table 42. Novartis Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Novartis Gene Therapies for Tumor Treatment Product Portfolio Table 44. Novartis Recent Development Table 45. Amgen Company Information Table 46. Amgen Business Overview Table 47. Amgen Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Amgen Gene Therapies for Tumor Treatment Product Portfolio Table 49. Amgen Recent Development Table 50. Sibiono Company Information Table 51. Sibiono Business Overview Table 52. Sibiono Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Sibiono Gene Therapies for Tumor Treatment Product Portfolio Table 54. Sibiono Recent Development Table 55. Gilead Sciences Company Information Table 56. Gilead Sciences Business Overview Table 57. Gilead Sciences Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Gilead Sciences Gene Therapies for Tumor Treatment Product Portfolio Table 59. Gilead Sciences Recent Development Table 60. North America Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 61. North America Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 62. North America Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 63. North America Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 64. North America Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 65. North America Gene Therapies for Tumor Treatment Market Size by Country (2021-2026) Table 66. North America Gene Therapies for Tumor Treatment Market Size by Country (2027-2032) Table 67. Europe Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 68. Europe Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 69. Europe Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 70. Europe Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 71. Europe Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 72. Europe Gene Therapies for Tumor Treatment Market Size by Country (2021-2026) Table 73. Europe Gene Therapies for Tumor Treatment Market Size by Country (2027-2032) Table 74. China Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 75. China Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 76. China Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 77. China Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 78. Asia Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 79. Asia Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 80. Asia Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 81. Asia Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 82. Asia Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 83. Asia Gene Therapies for Tumor Treatment Market Size by Country (2021-2026) Table 84. Asia Gene Therapies for Tumor Treatment Market Size by Country (2027-2032) Table 85. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2021-2026) & (US$ Million) Table 86. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2027-2032) & (US$ Million) Table 87. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2021-2026) & (US$ Million) Table 88. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2027-2032) & (US$ Million) Table 89. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2021-2026) Table 91. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2027-2032) Table 92. Research Programs/Design for This Report Table 93. Authors List of This Report Table 94. Secondary Sources Table 95. Primary Sources List of Figures Figure 1. Gene Therapies for Tumor Treatment Product Image Figure 2. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Gene Therapies for Tumor Treatment Market Share by Type: 2025 VS 2032 Figure 4. Oncolytic Virotherapy Image Figure 5. Gene Transfer Image Figure 6. Gene Induced Immunotherapy Image Figure 7. Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 8. Global Gene Therapies for Tumor Treatment Market Share by Application: 2025 VS 2032 Figure 9. Hospital Image Figure 10. Clinic Image Figure 11. Other Image Figure 12. Global Gene Therapies for Tumor Treatment Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 14. Global Gene Therapies for Tumor Treatment Market Share by Region: 2025 VS 2032 Figure 15. Years Considered Figure 16. Global Gene Therapies for Tumor Treatment Market Share by Players in 2025 Figure 17. Global Top 5 and 10 Gene Therapies for Tumor Treatment Players Market Share by Revenue in 2025 Figure 18. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Gene Therapies for Tumor Treatment Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Gene Therapies for Tumor Treatment Revenue Market Share by Type (2021-2032) Figure 21. Global Gene Therapies for Tumor Treatment Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Gene Therapies for Tumor Treatment Revenue Market Share by Application (2021-2032) Figure 23. North America Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 24. North America Gene Therapies for Tumor Treatment Market Share by Type (2021-2032) Figure 25. North America Gene Therapies for Tumor Treatment Market Share by Application (2021-2032) Figure 26. North America Gene Therapies for Tumor Treatment Market Share by Country (2021-2032) Figure 27. United States Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 28. Canada Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 29. Mexico Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 30. Europe Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 31. Europe Gene Therapies for Tumor Treatment Market Share by Type (2021-2032) Figure 32. Europe Gene Therapies for Tumor Treatment Market Share by Application (2021-2032) Figure 33. Europe Gene Therapies for Tumor Treatment Market Share by Country (2021-2032) Figure 34. Germany Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 35. France Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 36. U.K. Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 37. Italy Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 38. Russia Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 39. Nordic Countries Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 40. China Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 41. China Gene Therapies for Tumor Treatment Market Share by Type (2021-2032) Figure 42. China Gene Therapies for Tumor Treatment Market Share by Application (2021-2032) Figure 43. Asia Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 44. Asia Gene Therapies for Tumor Treatment Market Share by Type (2021-2032) Figure 45. Asia Gene Therapies for Tumor Treatment Market Share by Application (2021-2032) Figure 46. Asia Gene Therapies for Tumor Treatment Market Share by Country (2021-2032) Figure 47. Japan Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 48. South Korea Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 49. Taiwan Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 50. Southeast Asia Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 51. India Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 52. Australia Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 53. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Type (2021-2032) Figure 55. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Application (2021-2032) Figure 56. South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Country (2021-2032) Figure 57. Brazil Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 58. South Africa Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 59. Saudi Arabia Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 60. Turkey Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 61. Argentina Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 62. UAE Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 63. Egypt Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 64. Chile Gene Therapies for Tumor Treatment Market Size (2021-2032) & (US$ Million) Figure 65. Research Process Figure 66. Key Executives Interviewed

Scope & coverage.

Types
  • Oncolytic Virotherapy
  • Gene Transfer
  • Gene Induced Immunotherapy
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Shanghai Sunway
  • Novartis
  • Amgen
  • Sibiono
  • Gilead Sciences

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Oncolytic Virotherapy
  5. 1.2.3 Gene Transfer
  6. 1.2.4 Gene Induced Immunotherapy
  7. 1.3 Market Analysis by Application
  8. 1.3.1 Global Gene Therapies for Tumor Treatment Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Clinic
  11. 1.3.4 Other
  12. 1.4 Global Market Growth Prospects
  13. 1.5 Global Gene Therapies for Tumor Treatment Growth Trends by Region
  14. 1.5.1 Global Gene Therapies for Tumor Treatment Market Size by Region: 2021 VS 2025 VS 2032
  15. 1.5.2 Gene Therapies for Tumor Treatment Market Size by Region (2021-2026)
  16. 1.5.3 Gene Therapies for Tumor Treatment Market Size by Region (2027-2032)
  17. 1.6 Assumptions and Limitations
  18. 1.7 Study Goals and Objectives
  19. 1.8 Years Considered
2 Global Gene Therapies for Tumor Treatment Market Dynamics
  1. 2.1 Gene Therapies for Tumor Treatment Industry Trends
  2. 2.2 Gene Therapies for Tumor Treatment Industry Drivers
  3. 2.3 Gene Therapies for Tumor Treatment Industry Opportunities and Challenges
  4. 2.4 Gene Therapies for Tumor Treatment Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Gene Therapies for Tumor Treatment Revenue by Company (2021-2026)
  2. 3.2 Global Gene Therapies for Tumor Treatment Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Gene Therapies for Tumor Treatment Key Company Head office and Area Served
  4. 3.4 Global Gene Therapies for Tumor Treatment Company, Product Type & Application
  5. 3.5 Global Gene Therapies for Tumor Treatment Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Gene Therapies for Tumor Treatment Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Gene Therapies for Tumor Treatment Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Gene Therapies for Tumor Treatment Tier 1, Tier 2, and Tier 3
4 Gene Therapies for Tumor Treatment Market by Type
  1. 4.1 Global Gene Therapies for Tumor Treatment Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Gene Therapies for Tumor Treatment Market Size by Type (2021-2032)
  3. 4.3 Global Gene Therapies for Tumor Treatment Market Size Share by Type (2021-2032)
5 Gene Therapies for Tumor Treatment Market by Application
  1. 5.1 Global Gene Therapies for Tumor Treatment Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Gene Therapies for Tumor Treatment Market Size by Application (2021-2032)
  3. 5.3 Global Gene Therapies for Tumor Treatment Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Shanghai Sunway
  2. 6.1.1 Shanghai Sunway Company Information
  3. 6.1.2 Shanghai Sunway Business Overview
  4. 6.1.3 Shanghai Sunway Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Shanghai Sunway Gene Therapies for Tumor Treatment Product Portfolio
  6. 6.1.5 Shanghai Sunway Recent Developments
  7. 6.2 Novartis
  8. 6.2.1 Novartis Company Information
  9. 6.2.2 Novartis Business Overview
  10. 6.2.3 Novartis Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Novartis Gene Therapies for Tumor Treatment Product Portfolio
  12. 6.2.5 Novartis Recent Developments
  13. 6.3 Amgen
  14. 6.3.1 Amgen Company Information
  15. 6.3.2 Amgen Business Overview
  16. 6.3.3 Amgen Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Amgen Gene Therapies for Tumor Treatment Product Portfolio
  18. 6.3.5 Amgen Recent Developments
  19. 6.4 Sibiono
  20. 6.4.1 Sibiono Company Information
  21. 6.4.2 Sibiono Business Overview
  22. 6.4.3 Sibiono Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Sibiono Gene Therapies for Tumor Treatment Product Portfolio
  24. 6.4.5 Sibiono Recent Developments
  25. 6.5 Gilead Sciences
  26. 6.5.1 Gilead Sciences Company Information
  27. 6.5.2 Gilead Sciences Business Overview
  28. 6.5.3 Gilead Sciences Gene Therapies for Tumor Treatment Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Gilead Sciences Gene Therapies for Tumor Treatment Product Portfolio
  30. 6.5.5 Gilead Sciences Recent Developments
7 North America
  1. 7.1 North America Gene Therapies for Tumor Treatment Market Size (2021-2032)
  2. 7.2 North America Gene Therapies for Tumor Treatment Market Size by Type
  3. 7.2.1 North America Gene Therapies for Tumor Treatment Market Size by Type (2021-2026)
  4. 7.2.2 North America Gene Therapies for Tumor Treatment Market Size by Type (2027-2032)
  5. 7.2.3 North America Gene Therapies for Tumor Treatment Market Share by Type (2021-2032)
  6. 7.3 North America Gene Therapies for Tumor Treatment Market Size by Application
  7. 7.3.1 North America Gene Therapies for Tumor Treatment Market Size by Application (2021-2026)
  8. 7.3.2 North America Gene Therapies for Tumor Treatment Market Size by Application (2027-2032)
  9. 7.3.3 North America Gene Therapies for Tumor Treatment Market Share by Application (2021-2032)
  10. 7.4 North America Gene Therapies for Tumor Treatment Market Size by Country
  11. 7.4.1 North America Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Gene Therapies for Tumor Treatment Market Size by Country (2021-2026)
  13. 7.4.3 North America Gene Therapies for Tumor Treatment Market Size by Country (2027-2032)
  14. 7.4.4 North America Gene Therapies for Tumor Treatment Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Gene Therapies for Tumor Treatment Market Size (2021-2032)
  2. 8.2 Europe Gene Therapies for Tumor Treatment Market Size by Type
  3. 8.2.1 Europe Gene Therapies for Tumor Treatment Market Size by Type (2021-2026)
  4. 8.2.2 Europe Gene Therapies for Tumor Treatment Market Size by Type (2027-2032)
  5. 8.2.3 Europe Gene Therapies for Tumor Treatment Market Share by Type (2021-2032)
  6. 8.3 Europe Gene Therapies for Tumor Treatment Market Size by Application
  7. 8.3.1 Europe Gene Therapies for Tumor Treatment Market Size by Application (2021-2026)
  8. 8.3.2 Europe Gene Therapies for Tumor Treatment Market Size by Application (2027-2032)
  9. 8.3.3 Europe Gene Therapies for Tumor Treatment Market Share by Application (2021-2032)
  10. 8.4 Europe Gene Therapies for Tumor Treatment Market Size by Country
  11. 8.4.1 Europe Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Gene Therapies for Tumor Treatment Market Size by Country (2021-2026)
  13. 8.4.3 Europe Gene Therapies for Tumor Treatment Market Size by Country (2027-2032)
  14. 8.4.4 Europe Gene Therapies for Tumor Treatment Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Gene Therapies for Tumor Treatment Market Size (2021-2032)
  2. 9.2 China Gene Therapies for Tumor Treatment Market Size by Type
  3. 9.2.1 China Gene Therapies for Tumor Treatment Market Size by Type (2021-2026)
  4. 9.2.2 China Gene Therapies for Tumor Treatment Market Size by Type (2027-2032)
  5. 9.2.3 China Gene Therapies for Tumor Treatment Market Share by Type (2021-2032)
  6. 9.3 China Gene Therapies for Tumor Treatment Market Size by Application
  7. 9.3.1 China Gene Therapies for Tumor Treatment Market Size by Application (2021-2026)
  8. 9.3.2 China Gene Therapies for Tumor Treatment Market Size by Application (2027-2032)
  9. 9.3.3 China Gene Therapies for Tumor Treatment Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Gene Therapies for Tumor Treatment Market Size (2021-2032)
  2. 10.2 Asia Gene Therapies for Tumor Treatment Market Size by Type
  3. 10.2.1 Asia Gene Therapies for Tumor Treatment Market Size by Type (2021-2026)
  4. 10.2.2 Asia Gene Therapies for Tumor Treatment Market Size by Type (2027-2032)
  5. 10.2.3 Asia Gene Therapies for Tumor Treatment Market Share by Type (2021-2032)
  6. 10.3 Asia Gene Therapies for Tumor Treatment Market Size by Application
  7. 10.3.1 Asia Gene Therapies for Tumor Treatment Market Size by Application (2021-2026)
  8. 10.3.2 Asia Gene Therapies for Tumor Treatment Market Size by Application (2027-2032)
  9. 10.3.3 Asia Gene Therapies for Tumor Treatment Market Share by Application (2021-2032)
  10. 10.4 Asia Gene Therapies for Tumor Treatment Market Size by Country
  11. 10.4.1 Asia Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Gene Therapies for Tumor Treatment Market Size by Country (2021-2026)
  13. 10.4.3 Asia Gene Therapies for Tumor Treatment Market Size by Country (2027-2032)
  14. 10.4.4 Asia Gene Therapies for Tumor Treatment Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Gene Therapies for Tumor Treatment Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst